Description

Product details

Breathing is something most of us take for granted—until it becomes difficult. For people living with pulmonary arterial hypertension (PAH), even simple daily activities like walking, climbing stairs, or talking for extended periods can feel exhausting. Pulmonary arterial hypertension is a serious, progressive condition where the blood pressure in the arteries of the lungs becomes abnormally high, placing extra strain on the heart and lungs. AMBRISTAR 5, containing Ambrisentan 5 mg, is a targeted oral therapy designed to help manage pulmonary arterial hypertension effectively. It works by relaxing and widening the blood vessels in the lungs, improving blood flow, reducing strain on the heart, and enhancing a patient’s ability to stay active. AMBRISTAR 5 is prescribed as part of long-term treatment to slow disease progression, improve exercise capacity, and support better overall quality of life for individuals diagnosed with PAH. Composition Active Ingredient: Ambrisentan 5 mg Brand Name: AMBRISTAR 5 Dosage Form: Oral Tablet Therapeutic Class: Endothelin Receptor Antagonist (ERA) Ambrisentan is a selective endothelin receptor antagonist, specifically developed to target the biological pathways involved in pulmonary arterial hypertension. How AMBRISTAR 5 Works Pulmonary arterial hypertension is closely linked to increased levels of endothelin-1, a powerful chemical in the body that causes blood vessels to narrow and stiffen. In PAH patients, excess endothelin-1 leads to persistent tightening of pulmonary arteries, reduced blood flow, and increased pressure within the lungs. AMBRISTAR 5 works by blocking endothelin-1 receptors, which results in: Relaxation of lung blood vessels Improved blood circulation through the lungs Reduced pulmonary blood pressure Lower workload on the heart By addressing this key mechanism, AMBRISTAR 5 helps patients breathe easier and perform daily activities with less fatigue. Uses of AMBRISTAR 5 1. Pulmonary Arterial Hypertension (PAH) AMBRISTAR 5 is primarily used for the treatment of pulmonary arterial hypertension, especially in patients classified under WHO functional class II or III. 2. Improvement in Exercise Capacity The medication helps increase physical endurance, allowing patients to walk longer distances and perform daily tasks more comfortably. 3. Delay in Disease Progression Long-term use helps slow the worsening of PAH symptoms and supports better heart and lung function. 4. Combination Therapy AMBRISTAR 5 may be used alone or in combination with other PAH treatments, depending on the patient’s condition and physician recommendation. Key Benefits of AMBRISTAR 5 1. Improves Breathing Comfort By widening pulmonary blood vessels, AMBRISTAR 5 helps reduce breathlessness, especially during physical activity. 2. Enhances Exercise Tolerance Patients often experience increased stamina and endurance, allowing them to stay active for longer periods. 3. Reduces Pressure on the Heart Lower pulmonary pressure means reduced strain on the right side of the heart, helping maintain cardiac health. 4. Slows Disease Progression AMBRISTAR 5 addresses the underlying cause of PAH rather than just relieving symptoms. 5. Supports Long-Term Management Designed for chronic use under medical supervision, it fits well into long-term PAH treatment plans. 6. Improves Quality of Life With better breathing, less fatigue, and improved mobility, patients often report improved confidence and emotional well-being. Dosage and Administration The usual starting dose is Ambrisentan 5 mg once daily The tablet should be swallowed whole with water It can be taken with or without food Dose adjustments depend on patient response and physician evaluation Important: AMBRISTAR 5 should be taken exactly as prescribed. Do not skip doses or discontinue treatment without consulting a healthcare professional. Possible Side Effects of AMBRISTAR 5 Like all medicines, AMBRISTAR 5 may cause side effects, although not all patients experience them. Most side effects are mild to moderate and manageable. Common Side Effects Headache Nasal congestion Flushing Swelling of ankles or feet (peripheral edema) Dizziness Less Common Side Effects Nausea Fatigue Abdominal discomfort Palpitations Serious but Rare Side Effects Liver function abnormalities Decrease in hemoglobin levels (anemia) Fluid retention requiring medical attention Allergic reactions Routine blood tests are often recommended to monitor liver function and hemoglobin levels during treatment. Precautions and Warnings Pregnancy Warning: Ambrisentan can cause serious harm to an unborn baby. Effective contraception is mandatory for women of childbearing potential. Liver Monitoring: Regular liver function tests are advised during treatment. Anemia Risk: Periodic blood tests may be required to monitor hemoglobin levels. Fluid Retention: Patients should report sudden weight gain or swelling. Drug Interactions: Inform your doctor about all medications, supplements, or herbal products you are taking. Who Should Avoid AMBRISTAR 5? Pregnant women or those planning pregnancy Patients with severe liver impairment Individuals with known hypersensitivity to Ambrisentan Patients not enrolled in appropriate monitoring programs, where required Storage Instructions Store below 25°C Protect from moisture and direct sunlight Keep out of reach of children Do not use after the expiry date Conclusion AMBRISTAR 5 (Ambrisentan 5 mg) is a well-established and targeted therapy for the management of pulmonary arterial hypertension. By blocking endothelin-mediated blood vessel constriction, it improves blood flow in the lungs, reduces pressure on the heart, and significantly enhances exercise capacity and daily comfort. For patients facing the challenges of PAH, AMBRISTAR 5 offers more than symptom relief—it provides a pathway toward better disease control, improved physical endurance, and a more active, confident life. When used under proper medical supervision with regular monitoring, AMBRISTAR 5 plays a vital role in comprehensive pulmonary hypertension care.

Other Specifications